In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest on: Genome editing
expert reaction to genome-edited pigs for viral resistance
on June 20, 2018 at 10:38 am
Prof Jonathan Ball, Professor of Molecular Virology at the University of Nottingham, said: “This is a neat illustration of how the gene editing technique known as CRISPR/Cas can be used to manipulate a genome, in this case pigs, so that it becomes ... […]
CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing
on June 19, 2018 at 6:38 am
ZUG, Switzerland and CAMBRIDGE, Mass. and BERKELEY, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), Intellia Therapeutics, Inc. (NASDAQ:NTLA), and Caribou Biosciences, Inc., announced that The Regents of the University of ... […]
Gene editing technology predicts heart disease risk
on June 18, 2018 at 6:06 am
Image Credit: Yurchanka Siarhei / Shutterstock This is the first time a study has demonstrated the potential of combining stem cell-based disease modeling with CRISPR/Cas 9-mediated genome editing, to determine the pathogenic ability of an undescribed gene ... […]
Genome Editing/Genome Engineering Market Analysis Leading Manufacturers Merck KGaA, Horizon Discovery Group, Genscript USA
on June 15, 2018 at 4:29 pm
A new business intelligence report released by HTF MI with title “Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the ... […]
Qatar- Genome-editing tool could raise cancer risk
on June 14, 2018 at 12:29 am
(MENAFN - Gulf Times) Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published in ... […]
Genome-editing tool could raise cancer risk
on June 13, 2018 at 12:28 pm
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published in Nature Medicine. […]
Gene editing for cancer prevention may actually cause cancer
on June 12, 2018 at 3:05 am
The past few years have seen a rising interest in the development of genome editing, or "gene editing." Gene editing is the use of highly sensitive and precise technologies that let specialists alter segments of human DNA for therapeutic purposes. […]
Genome-editing tool may inadvertently increase the risk of cancer
on June 12, 2018 at 2:51 am
LONDON: Therapeutic use of a popular gene editing technique may inadvertently increase the risk of cancer, according to a study. Researchers from Karolinska Institute, Sweden, and the University of Helsinki in Finland say that more studies are required in ... […]
The startling future of DNA genome editing
on June 11, 2018 at 2:00 pm
TechRepublic's Teena Maddox talked with Rodolphe Barrangou, an associate professor of food science from North Carolina State University, about the developing technology CRISPR. Watch the video, or read the transcript below: Barrangou: So CRISPR is a ... […]
Genome-editing tool could increase cancer risk
on June 11, 2018 at 8:09 am
Therapeutic use of gene editing with the CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study from Karolinska Institutet, Sweden, and the University of Helsinki, Finland, published in Nature Medicine. Researchers ... […]
via Google News and Bing News